NO124255B - - Google Patents
Download PDFInfo
- Publication number
- NO124255B NO124255B NO0667/69A NO66769A NO124255B NO 124255 B NO124255 B NO 124255B NO 0667/69 A NO0667/69 A NO 0667/69A NO 66769 A NO66769 A NO 66769A NO 124255 B NO124255 B NO 124255B
- Authority
- NO
- Norway
- Prior art keywords
- dimethylhydantoin
- compound
- chloral
- chloral hydrate
- new
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims description 11
- YIROYDNZEPTFOL-UHFFFAOYSA-N 5,5-Dimethylhydantoin Chemical compound CC1(C)NC(=O)NC1=O YIROYDNZEPTFOL-UHFFFAOYSA-N 0.000 claims description 6
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 claims description 4
- 229960002327 chloral hydrate Drugs 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- HFFLGKNGCAIQMO-UHFFFAOYSA-N trichloroacetaldehyde Chemical compound ClC(Cl)(Cl)C=O HFFLGKNGCAIQMO-UHFFFAOYSA-N 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- RMAQNKZXBKKKPV-UHFFFAOYSA-N ClC(C(O)O)(Cl)Cl.CC1(C(NC(N1)=O)=O)C Chemical compound ClC(C(O)O)(Cl)Cl.CC1(C(NC(N1)=O)=O)C RMAQNKZXBKKKPV-UHFFFAOYSA-N 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000008298 dragée Substances 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000007665 chronic toxicity Effects 0.000 description 1
- 231100000160 chronic toxicity Toxicity 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- ACXCKRZOISAYHH-UHFFFAOYSA-N molecular chlorine hydrate Chemical compound O.ClCl ACXCKRZOISAYHH-UHFFFAOYSA-N 0.000 description 1
- 239000011049 pearl Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000002557 soporific effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100001274 therapeutic index Toxicity 0.000 description 1
- 229940029273 trichloroacetaldehyde Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/74—Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C31/00—Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C31/34—Halogenated alcohols
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HUCI000782 | 1968-02-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO124255B true NO124255B (ja) | 1972-03-27 |
Family
ID=10994348
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO0667/69A NO124255B (ja) | 1968-02-21 | 1969-02-19 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US3652582A (ja) |
| AT (1) | AT289744B (ja) |
| BE (1) | BE728770A (ja) |
| CA (1) | CA948640A (ja) |
| CH (1) | CH511237A (ja) |
| DE (1) | DE1908123A1 (ja) |
| FI (1) | FI49615C (ja) |
| FR (1) | FR2002348A1 (ja) |
| GB (1) | GB1218161A (ja) |
| IL (1) | IL31676A (ja) |
| NL (1) | NL6902706A (ja) |
| NO (1) | NO124255B (ja) |
| SE (1) | SE349577B (ja) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3008296C2 (de) * | 1980-03-04 | 1987-02-19 | Brose Fahrzeugteile GmbH & Co KG, 8630 Coburg | Vorrichtung zum Antrieb einer Seiltrommel eines Seilfensterhebers |
-
1969
- 1969-02-18 SE SE02242/69A patent/SE349577B/xx unknown
- 1969-02-18 CH CH243869A patent/CH511237A/de not_active IP Right Cessation
- 1969-02-18 FI FI690506A patent/FI49615C/fi active
- 1969-02-18 US US800287A patent/US3652582A/en not_active Expired - Lifetime
- 1969-02-19 DE DE19691908123 patent/DE1908123A1/de active Pending
- 1969-02-19 AT AT164969A patent/AT289744B/de not_active IP Right Cessation
- 1969-02-19 NO NO0667/69A patent/NO124255B/no unknown
- 1969-02-20 NL NL6902706A patent/NL6902706A/xx unknown
- 1969-02-20 GB GB9333/69A patent/GB1218161A/en not_active Expired
- 1969-02-21 FR FR6904466A patent/FR2002348A1/fr not_active Withdrawn
- 1969-02-21 CA CA043,613A patent/CA948640A/en not_active Expired
- 1969-02-21 IL IL31676A patent/IL31676A/en unknown
- 1969-02-21 BE BE728770D patent/BE728770A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL31676A (en) | 1972-03-28 |
| GB1218161A (en) | 1971-01-06 |
| IL31676A0 (en) | 1969-04-30 |
| FR2002348A1 (fr) | 1969-10-17 |
| NL6902706A (ja) | 1969-08-25 |
| FI49615C (fi) | 1975-08-11 |
| DE1908123A1 (de) | 1969-10-09 |
| SE349577B (ja) | 1972-10-02 |
| BE728770A (ja) | 1969-08-01 |
| CH511237A (de) | 1971-08-15 |
| FI49615B (ja) | 1975-04-30 |
| US3652582A (en) | 1972-03-28 |
| AT289744B (de) | 1971-05-10 |
| CA948640A (en) | 1974-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SU812182A3 (ru) | Способ получени 7-метокси-1- ОКСАдЕТиАцЕфАлОСпОРиНОВ или иХСОлЕй | |
| JP7264999B2 (ja) | ２－（１－アシルオキシ－ｎ－ペンチル）安息香酸と塩基性アミノ酸またはアミノグアニジンによって形成される塩と、その製造方法及び用途 | |
| JPH0136819B2 (ja) | ||
| JPS63159385A (ja) | マロン酸誘導体及びその製法並びにその用途 | |
| TW460465B (en) | 1,2,3,4-tetrahydroquinoline derivatives, preparation process thereof, and pharmaceutical compositions containing the same | |
| US4073895A (en) | Isopropylamino pyrimidine orthophosphate | |
| KR20200041336A (ko) | 지방성 간 질환의 치료제 및 비만증의 치료제 | |
| DE3215610C2 (de) | N-Acylthiazolidine, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| CN105531270B (zh) | (+)－5－(3，4－二氟苯基)－5－[(3－甲基－2－氧吡啶－1(2h)－基)甲基]咪唑烷－2，4－二酮及含有该化合物的药物 | |
| US4127671A (en) | P-acetamidophenyl diethylaminoacetate | |
| KR840000702B1 (ko) | 빈카민 사카리네이트의 제조방법 | |
| NO124255B (ja) | ||
| JPS5829782A (ja) | 新規複素環化合物、その製法及び該化合物を含有する医薬組成物 | |
| US3377241A (en) | Certain diacyl derivatives of phloroglucinol as anthelmintics | |
| DK154136B (da) | Analogifremgangsmaade til fremstilling af 2-amino-3-benzoylphenylacetamider | |
| SE453387B (sv) | 2-amino-3-(halogenbensoyl)-metylfenylettikssyror, estrar och salter derav | |
| US3143469A (en) | Anti-cholesterol nicotinic acid nu-oxide | |
| DE1695855C3 (de) | 4-(5-Isobutyl-2-pyrimidinyl)-sulfonamidophenylessigsäure-(2-methoxy-5chloranilid) und dessen Salze mit physiologisch verträglichen Basen | |
| HU181608B (en) | Process for producing imidazo-thieno-pyrimidine derivatives | |
| US4267181A (en) | Halogeno derivatives of isopropylamino pyrimidine and therapeutic use | |
| US2721203A (en) | Chloral nicotinamide and method for preparing the same | |
| JPS6157312B2 (ja) | ||
| JPS5910563A (ja) | α−（Ｎ−ピロリル）−フエニル酢酸誘導体およびその製造方法 | |
| CA2836728C (en) | 5-carbamoyl-adamantan-2-yl amide derivatives, pharmaceutically acceptable salts thereof and preparation process thereof | |
| US3487153A (en) | Method of treating mental depression |